EcoDrugPlus

Carbonic Anhydrase 5a

Ensembl ID : ENSFCAG00000041876
Gene Symbol: CA5A
5 Cross references
170 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSFCAG00000008238
Gene Symbol: CA6
5 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSFCAG00000012773
Gene Symbol: CA7
5 Cross references
221 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSFCAG00000043895
Gene Symbol: CA9
5 Cross references
283 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSFCAG00000002814
Gene Symbol: CSNK1E
5 Cross references
264 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSFCAG00000003280
Gene Symbol: CSNK2A1
4 Cross references
138 Possible Orthologues:

Caspase 8

Ensembl ID : ENSFCAG00000025854
Gene Symbol: CASP8
5 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSFCAG00000026776
Gene Symbol: CASP9
5 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSFCAG00000002684
Gene Symbol: COMT
5 Cross references
277 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSFCAG00000008445
Gene Symbol: CTSC
5 Cross references
235 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSFCAG00000003643
Gene Symbol: CTSK
5 Cross references
246 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSFCAG00000003642
Gene Symbol: CTSS
5 Cross references
270 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).